Sun Pharma numbers were slightly below expectations in terms of EBITDA and we do think that though they have guided for a very strong growth through their speciality portfolio, that is a little bit time away.
Uday Kotak questions SpaceX valuation, says only time will tell if we’re in ‘mega bubble’
Uday Kotak described SpaceX’s blockbuster IPO as a test for capitalism, questioning whether investors are backing humanity’s future or fueling a massive bubble. His remarks